93199-8
LaboratoryDPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Definition
The test includes targeted analysis of variants in the DPYD gene by various molecular pathology methods, including PCR and sequencing. Testing may be performed to identifying individuals at increased risk of toxicity when considering 5-fluorouracil (5-FU) and capecitabine chemotherapy treatment. Variations detected in the DPYD gene are also associated with dihydropyrimidine dehydrogenase (DPD) deficiency.
LOINC 6-Axis Classification
Component
DPYD gene targeted mutation analysis
Property
Find
Time Aspect
Pt
System
Bld/Tiss
Scale Type
Doc
Method Type
Molgen
Details
Class
MOLPATH.PHARMG
Order/Observation
Both
Short Name
DPYD gene Mut Anl Bld/T
Display Name
DPYD gene targeted mutation analysis Molgen Doc (Bld/Tiss)
Related Names
Frequently Asked Questions
What is LOINC code 93199-8?
LOINC code 93199-8 identifies "DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method". The test includes targeted analysis of variants in the DPYD gene by various molecular pathology methods, including PCR and sequencing. Testing may be performed to identifying individuals at increased risk of toxicity when considering 5-fluorouracil (5-FU) and capecitabine chemotherapy treatment. Variations detected in the DPYD gene are also associated with dihydropyrimidine dehydrogenase (DPD) deficiency.
What does 93199-8 measure?
This code measures DPYD gene targeted mutation analysis in Bld/Tiss. It belongs to the MOLPATH.PHARMG class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.